Jennifer K. Moses

2022

In 2022, Jennifer K. Moses earned a total compensation of $1.1M as Former Chief Financial Officer at G1 Therapeutics, a 25% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$154,534
Option Awards$380,207
Salary$465,465
Stock Awards$128,280
Other$9,150
Total$1,137,636

Moses received $465.5K in salary, accounting for 41% of the total pay in 2022.

Moses also received $154.5K in non-equity incentive plan, $380.2K in option awards, $128.3K in stock awards and $9.2K in other compensation.

Rankings

In 2022, Jennifer K. Moses' compensation ranked 2,781st out of 5,736 executives tracked by ExecPay. In other words, Moses earned more than 51.5% of executives.

ClassificationRankingPercentile
All
2,781
out of 5,736
52nd
Division
Manufacturing
1,549
out of 3,125
50th
Major group
Chemicals And Allied Products
718
out of 1,416
49th
Industry group
Drugs
670
out of 1,317
49th
Industry
Pharmaceutical Preparations
484
out of 963
50th

Pay ratio

Jennifer K. Moses' Pay$1,137,636
Median Employee's Pay$243,930
Pay Ratio

5

to 1

In 2022, the annual total compensation of Jennifer K. Moses was $1,137,636.

The annual total compensation of the median employee at G1 Therapeutics was $243,930.

The ratio of Jennifer K. Moses' pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 26, 2023.

Moses' colleagues

We found two more compensation records of executives who worked with Jennifer K. Moses at G1 Therapeutics in 2022.

2022

John Bailey

G1 Therapeutics

Chief Executive Officer

2022

Mark Avagliano

G1 Therapeutics

Chief Business Officer

News

You may also like